MaxWell Biosciences MaxWell Biosciences
search
  • Home
  • About
  • Products
    • Heterochronic Optimized Plasma Exchange
    • MaxWell Brain
  • Team
  • Articles
    • Research
    • News
  • Contact
menu
Research
  • LL-37 Cathelicidin Antimicrobial Peptide – An Alzheimer’s Disease Therapy Candidate
  • What is Alzheimer’s
  • Biomarkers of Alzheimer’s Disease
  • Type 1 Alzheimer’s – Inflammatory
  • Lymphatic Fluid and Immunotherapy
More research...
News
  • The Future of Alzheimer’s: The Future of Everything interview with Dr Annelise Barron
  • “Emerging Therapies Act of 2017” Signed into Arkansas Law
  • Early Detection of Alzheimer’s Disease In Blood Platelets
More news...
COMPANY
  • About
  • Careers
  • Team
  • Research
  • News
  • Contact
PRODUCTS
  • Heterochronic Optimized Plasma Exchange
  • MaxWell Brain
SERVICES
  • The HOPE Trial
  • Prevention or reversal of dementia
  • Optimizing brain performance
MaxWell Biosciences

Copyright © 2016 - 2018. MaxWell Biosciences, Soldara Institute and HealthAnon are trademarked DBAs of Health Anonymous, a Public Benefit Corporation.
All rights reserved.

Unless otherwise stated, the information on this website has not been evaluated by the Food & Drug Administration or any other medical body. As a research organization, we do not diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition.